Start for free
Start for free
JM

John Maraganore

North America, Massachusetts, United States, Boston

Description

Chief Executive Officer & Director at Alnylam Pharmaceuticals.

Investor Profile

John Maraganore has made 5 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (60%)
  • Series Unknown (20%)
  • Series A (20%)

Country Focus

  • United States (60%)
  • The Netherlands (20%)

Industry Focus

  • Biotechnology
  • Medical
  • Biopharma
  • Health Care
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John Maraganore frequently co-invest with?

Arranta Bio
Arranta Bio
North America, Massachusetts, United States, Watertown
Co-Investments: 1
Bruker
Bruker
North America, Massachusetts, United States, Billerica
Co-Investments: 1
HM
Hawktail Management
North America, California, United States, Palo Alto
Co-Investments: 1
UD
Uncommon Denominator
North America, New York, United States, New York
Co-Investments: 1
Olive Capital
Olive Capital
North America, California, United States, San Francisco
Co-Investments: 1
Pillar VC
Pillar VC
North America, Massachusetts, United States, Boston
Co-Investments: 1
MV
Magnetic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Brainstorm Ventures
Brainstorm Ventures
North America, California, United States, San Francisco
Co-Investments: 1
NV
NYBC Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does John Maraganore often collaborate with?

David Meeker
David Meeker
North America, Massachusetts, United States, Boston
Shared Deals: 1
JE
John Evans
North America, New York, United States, New York
Shared Deals: 1
DA
Daniel A. de Boer
Europe, Zuid-Holland, The Netherlands, Leiden
Shared Deals: 1
PR
Philip Reilly
North America, Massachusetts, United States, Boston
Shared Deals: 1
BD
Bassil Dahiyat
North America, California, United States, Monrovia
Shared Deals: 1
JP
Judy Pagliuca
North America, United States
Shared Deals: 1
GC
George Church
North America, Massachusetts, United States, Boston
Shared Deals: 1
MB
Mark Bamforth
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by John Maraganore?

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

Biotechnology
SeedFeb 12, 2025
Amount Raised: $9,000,000
Terray Therapeutics

Pasadena, California, United States

Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.

Artificial Intelligence (AI)BiopharmaBiotechnologyLife ScienceMedical
Series UnknownNov 9, 2023
Thymmune Therapeutics

Cambridge, Massachusetts, United States

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

BiotechnologyTherapeutics
SeedMar 1, 2023
Amount Raised: $7,000,000
Lipidio Pharmaceuticals

San Diego, California, United States

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

BiopharmaBiotechnologyHealth CareMedical
Series ANov 10, 2022
Amount Raised: $20,000,000
Xinvento

Amsterdam, Noord-Holland, The Netherlands

Xinvento provides a credible alternative treatment for congenital hyperinsulinism.

Health CareMedical
SeedApr 21, 2022
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator